Bristol Myers (BMY) ebitda was $24.2B in FY2020 (+164% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2020
$24.2B
+164%
2019
$9.2B
+53%
2018
$6.0B
+35%
2017
$4.5B
-12%
2016
$5.1B
+103%
2015
$2.5B
-24%
2014
$3.3B
-19%
2013
$4.0B
-30%
2012
$5.8B
-31%
2011
$8.4B
+8%
2010
$7.8B
+15%
2009
$6.7B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$4.7B
Q1 2026
$4.5B
Q4 2025
$6.4B
Q3 2025
$4.8B
Q2 2025
$4.9B
Q1 2025
$5.5B
Q4 2024
$9.1B
Q3 2024
$4.9B
Q2 2024
$4.4B
Q1 2024
$6.5B
Q4 2023
$11.3B
Q3 2023
$4.5B
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.